Mostrar el registro sencillo del ítem

dc.contributor.authorTrapero Bertrán, Marta 
dc.contributor.authorMuñoz, Celia 
dc.contributor.authorCoyle, Kathryn 
dc.contributor.authorCoyle, Doug 
dc.contributor.authorLester George, Adam 
dc.contributor.authorLeidl, Reiner 
dc.contributor.authorNémeth, Bertalan 
dc.contributor.authorCheung, Kei-Long 
dc.contributor.authorPokhrel, Subhash 
dc.contributor.authorLópez Nicolás, Ángel 
dc.date.accessioned2019-05-03T12:23:19Z
dc.date.available2019-05-03T12:23:19Z
dc.date.issued2018-06-18
dc.identifier.citationEn Addiction, 113 (Suppl. 1), 65–75es_ES
dc.identifier.issn1360-0443
dc.description.abstractAIMS: To assess the cost-effectiveness of alternative smoking cessation scenarios from the perspective of the Spanish National Health Service (NHS). DESIGN: We used the European study on Quantifying Utility of Investment in Protection from Tobacco model (EQUIPTMOD), a Markov-based state transition economic model, to estimate the return on investment (ROI) of: (a) the current provision of smoking cessation services (brief physician advice and printed self-helped material + smoking ban and tobacco duty at current levels); and (b) four alternative scenarios to complement the current provision: coverage of proactive telephone calls; nicotine replacement therapy (mono and combo) [prescription nicotine replacement therapy (Rx NRT)]; varenicline (standard duration); or bupropion. A rate of 3% was used to discount life-time costs and benefits. SETTING: Spain. PARTICIPANTS: Adult smoking population (16+ years). MEASUREMENTS: Health-care costs associated with treatment of smoking attributable diseases (lung cancer, coronary heart disease, chronic obstructive pulmonary infection and stroke); intervention costs; quality-adjusted life years (QALYs). Costs and outcomes were summarized using various ROI estimates. FINDINGS: The cost of implementing the current provision of smoking cessation services is approximately €61 million in the current year. This translates to 18 quitters per 1000 smokers and a life-time benefit-cost ratio of 5, compared with no such provision. All alternative scenarios were dominant (cost-saving: less expensive to run and generated more QALYs) from the life-time perspective, compared with the current provision. The life-time benefit-cost ratios were: 1.87 (proactive telephone calls); 1.17 (Rx NRT); 2.40 (varenicline-standard duration); and bupropion (2.18). The results remained robust in the sensitivity analysis. CONCLUSIONS: According to the EQUIPTMOD modelling tool it would be cost-effective for the Spanish authorities to expand the reach of existing GP brief interventions for smoking cessation, provide pro-active telephone support, and reimburse smoking cessation medication to smokers trying to stop. Such policies would more than pay for themselves in the long run.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherJohn Wiley & Sons Ltd on behalf of Society for the Study of Addictiones_ES
dc.relation.urihttps://www.ncbi.nlm.nih.gov/pubmed/29532966es_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titleCost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMODes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.subject.otherEconomía Financiera y Contabilidades_ES
dc.subjectCost-effectivenesses_ES
dc.subjectEQUIPTes_ES
dc.subjectSmoking cessation interventionses_ES
dc.subjectTobacco controles_ES
dc.identifier.urihttp://hdl.handle.net/10317/7741
dc.peerreviewSies_ES
dc.identifier.doi10.1111/add.14090
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.unesco3212 Salud Publicaes_ES


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España